Hong Kong stocks abnormal | Concept stocks of innovative drugs rebounded today, with many stocks rising by more than 4%. Institutions say they are focusing on the release of the medical insurance and commercial insurance innovative drug catalogs.

According to the Securities Times APP, the concept stocks of innovative drugs rebounded today. As of the press release, Guolian Pharmaceutical-B (01672.HK) rose by 10.26% to 13.11 Hong Kong dollars; Kangfang Biotech (09926.HK) rose by 4.15% to 123.1 Hong Kong dollars; Zaiding Medicine (09688.HK) rose by 3.36% to 15.69 Hong Kong dollars; Sinopharm Group (02096) rose by 2.9% to 13.48 Hong Kong dollars.